Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

    NEXT STORY
    Eldorado Gold Completes Acquisition of QMX Gold
    PREV STORY
    PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human growth hormone treatment system
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immunomedics Appoints Michael Pehl President and Chief Executive Officer to Lead Next Phase of Transformative Growth

    MORRIS PLAINS, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ:IMMU) (“Immunomedics” or ...

    author_avatar
    NASDAQ Market News

    Valeritas’ V-Go® Wearable Insulin Delivery Device Provides Clinical and Economic Benefits, A1C Response and Lower Total Daily Insulin Dose through Prospective Randomized Trial and Real-World Use by Patients with Type 2 Diabetes

    BRIDGEWATER, N.J., June 12, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced ...

    author_avatar
    NASDAQ Market News

    Basilea announces completion of patient enrolment in phase 1 study with oral BAL101553 in brain cancer

    author_avatar
    NASDAQ Market News